eLaws | eCases | United States Code | Federal Courts |

Express Scripts - Comment

Document ID: FDA-2011-N-0898-0008
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: February 16 2012, at 12:00 AM Eastern Standard Time
Date Posted: March 1 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: December 19 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: February 17 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80fb8414
View Document:

This is comment on Rule

Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance

View Comment

Please see the attached comments

Attachments:

Express Scripts - 021712 ESI comments to FDA IFR

Title:
Express Scripts - 021712 ESI comments to FDA IFR

View Attachment:

View as format pdf

Related Comments

View All

Total: 12

American Society of Health-System Pharmacists (ASHP) - Comment
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0003

Comment Period Closed
Feb 17,2012 11:59 PM ET

American Hospital Association - Comment
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0004

Comment Period Closed
Feb 17,2012 11:59 PM ET

Colon Cancer Alliance - Comment
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0005

Comment Period Closed
Feb 17,2012 11:59 PM ET

AstraZeneca - Comment
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0007

Comment Period Closed
Feb 17,2012 11:59 PM ET

American Society of Hematology (ASH) - Comment
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0009

Comment Period Closed
Feb 17,2012 11:59 PM ET